IBB

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 24)

The private bank to Queen Elizabeth II is lavishing millions of dollars in a high-stakes bet on a Brexit deal in the teeth of market scepticism.

Strategists predict a tougher period ahead for U.S. corporate bonds after a slide in equities to more appealing levels.

https://twitter.com/W7VOA/status/1309184827745337345

Immunome Inc. undefined set terms for its initial public offering, in which the Pennsylvania-based biopharmaceutical company focused on oncology looks to...

Inflation, dormant for a decade, captured the market’s attention all summer, with unprecedented Federal Reserve stimulus and a $2 trillion federal spending package set to juice prices.

The exodus from high-yield debt shows few signs of easing, with investors pulling hundreds of millions of dollars more from the largest exchange-traded funds that buy junk bonds as a global index tracking the securities erases its 2020 gains.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 23)